Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypsin-3, also known as mesotrypsin and encoded by the PRSS3 gene, is one of three major human trypsin isoforms produced by the pancreas[5]. It is a serine protease enzyme responsible for the proteolytic cleavage of peptide bonds following lysine or arginine residues, primarily facilitating dietary protein digestion in the small intestine[8][5]. Unlike the more abundant trypsin-1 and trypsin-2, Trypsin-3 is notable for its resistance to common polypeptide trypsin inhibitors due to a unique structural modification (an arginine residue near its specificity pocket), allowing it to play a specialized role in degrading dietary and endogenous trypsin inhibitors that would otherwise impede protein digestion[5]. It is synthesized as an inactive zymogen (trypsinogen-3), secreted into the duodenum, and activated by enterokinase. Beyond its digestive function, Trypsin-3 can activate other digestive zymogens, participate in modulating inflammatory processes (notably via protease-activated receptors, especially PAR2), and has roles in metabolic regulation and disease pathogenesis, including possible involvement in pancreatic pathology, inflammation, and neurodegenerative diseases[4][5][8].
Proteolytic cleavage of peptide bonds after lysine or arginine - Inhibition by direct binding to active site (for inhibitors) - Drug inhibition by covalent or non-covalent binding to catalytic residues or substrate pocket
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypsin-3 (PRSS3).